ECS vs RHY

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ECS

ECSBOTANIC FPO [ECS]

50MEDIUM

RHY

RHYTHM BIO FPO [RHY]

50MEDIUM

Score Breakdown

ECS RHY
Technical
33
34
Catalyst
53
51
Sentiment
50
50
Fundamental
61
34
Momentum
53
50
Risk Gate
27
50

Key Metrics

ECS Metric RHY
$8.0MMarket Cap$32.2M
1.4MAvg Volume (20d)284K
N/AShort InterestN/A
$0.01052-Week High$0.280
$0.00352-Week Low$0.052
-20.0%Daily Change-3.3%
$0.004Entry Price$0.088
N/AROE-190.1%
N/AProfit MarginN/A

Active Signals

ECS Signals

RSI drifting toward oversold territory — worth watching
Stochastic turning bearish from a high level — caution
Trading below both moving averages — the trend is working against this one
Took a hit — down 20.0% over the last 5 days
Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
Below the 200-day average — the long-term trend is still working against it
Strong cash runway (16 quarters)
Very high P/S ratio (2211.4x)

RHY Signals

RSI drifting toward oversold territory — worth watching
Stochastic is deep in oversold territory — bounce conditions forming
Trading below both moving averages — the trend is working against this one
Broke below 20-day support — that's a level the market was defending, and it just gave way
Lagging the Small Ords index — relative strength of 0.82, underperforming its peers
Below the 200-day average — the long-term trend is still working against it
Critical cash runway (1.1 quarters)
Revenue in sharp decline (-49%)

Ask Scout AI to compare ECS and RHY in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
ECS Full Analysis → RHY Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).